Insulin Lispro Patent Expiration
Insulin Lispro is Used for improving glycemic control in diabetes mellitus patients. It was first introduced by Sanofi-Aventis Us Llc
Insulin Lispro Patents
Given below is the list of patents protecting Insulin Lispro, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Admelog Solostar | US9717852 | Cartridge holder and pen-type injector | Apr 08, 2033 | Sanofi-aventis Us |
| Admelog Solostar | US7918833 | Pen-type injector | Sep 23, 2027 | Sanofi-aventis Us |
| Admelog Solostar | US8679069 | Pen-type injector | Apr 12, 2025 | Sanofi-aventis Us |
| Admelog Solostar | US8512297 | Pen-type injector |
Sep 15, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9561331 | Drive mechanisms suitable for use in drug delivery devices |
Aug 28, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9623189 | Relating to drive mechanisms suitable for use in drug delivery devices |
Aug 19, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9533105 | Drive mechanisms suitable for use in drug delivery devices |
Aug 17, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9604009 | Drive mechanisms suitable for use in drug delivery devices |
Aug 16, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US8992486 | Pen-type injector |
Jun 05, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9011391 | Pen-type injector |
Mar 26, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9827379 | Drive mechanisms suitable for use in drug delivery devices |
Mar 04, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US8556864 | Drive mechanisms suitable for use in drug delivery devices |
Mar 03, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US8603044 | Pen-type injector |
Mar 02, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9233211 | Relating to a pen-type injector |
Mar 02, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9408979 | Pen-type injector |
Mar 02, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9526844 | Pen-type injector |
Mar 02, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9604008 | Drive mechanisms suitable for use in drug delivery devices |
Mar 02, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9610409 | Drive mechanisms suitable for use in drug delivery devices |
Mar 02, 2024
(Expired) | Sanofi-aventis Us |
| Admelog Solostar | US9775954 | Pen-type injector |
Mar 02, 2024
(Expired) | Sanofi-aventis Us |
Insulin Lispro's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List